HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Exchange transfusion of least incompatible blood for severe hemolytic disease of the newborn due to anti-Rh17.

Abstract
HDN attributed to the rare Rh variants has become more and more significant caused by anti-D, but the compatible blood is usually very difficult to obtain when exchange transfusion is required. We treated a 10-hour neonate of O, D + C + c - E - e+ blood group with severe HDN due to anti-Rh17 with least incompatible blood typed O, D + C - c + E + e-. The neonatal hemolysis was relieved obviously and bilirubin was reduced gradually after exchange transfusion. The infant was discharged in good health 13 days after birth with 135.0 g/L, 28.0 micromol/L and 10.7 micromol/L of Hb, total bilirubin and direct bilirubin, respectively. No sequelae were observed in a three-year follow-up. The result suggesting that the least incompatible blood is an alternative choice for exchange transfusion in severe HDN due to anti-Rh17 in case that Rh17 antigen-negative blood is unavailable.
AuthorsBi-juan Li, Yuan-jun Jiang, Fen Yuan, Hong-xing Ye
JournalTransfusion medicine (Oxford, England) (Transfus Med) Vol. 20 Issue 1 Pg. 66-9 (Feb 2010) ISSN: 1365-3148 [Electronic] England
PMID19725902 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Immunoglobulins, Intravenous
  • Immunosuppressive Agents
  • Isoantibodies
  • RHO(D) antibody
  • Rh-Hr Blood-Group System
  • Rho(D) Immune Globulin
  • Rho(D) antigen
  • Methylprednisolone
Topics
  • Adult
  • Blood Component Transfusion (methods)
  • Blood Group Incompatibility (drug therapy, immunology)
  • Blood Grouping and Crossmatching
  • Erythrocyte Transfusion
  • Female
  • Humans
  • Hydrops Fetalis (immunology, therapy)
  • Hyperbilirubinemia, Neonatal (etiology, radiotherapy, therapy)
  • Immunoglobulins, Intravenous (therapeutic use)
  • Immunosuppressive Agents (therapeutic use)
  • Infant, Newborn
  • Isoantibodies (immunology)
  • Leukocyte Reduction Procedures
  • Male
  • Methylprednisolone (therapeutic use)
  • Plasma
  • Pregnancy
  • Rh Isoimmunization
  • Rh-Hr Blood-Group System (immunology)
  • Rho(D) Immune Globulin
  • Ultraviolet Therapy
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: